TC
ATRC icon

TFS Capital’s AtriCure ATRC Stock Holding History

TFS Capital’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-57,214
Closed -$1.08M – 1118
2014
Q1 		$1.08M Sell
57,214
-100,428
-64% -$2.06M 0.07% 426
2013
Q4 		$2.94M Buy
157,642
+79,274
+101% +$1.15M 0.14% 210
2013
Q3 		$860K Buy
78,368
+12,807
+20% +$126K 0.04% 642
2013
Q2 		$623K Buy
+65,561
New +$571K 0.03% 819

Other funds holding ATRC

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TFS Capital's ATRC Position: Q2 2014 in Review

TFS Capital sold out of AtriCure (ATRC) in Q2 2014, closing a stake of 57,214 shares — an estimated $1.08M sold.

TFS Capital first reported a position in ATRC in Q2 2013 and held it in 4 quarters. The position peaked at $2.94M in Q4 2013. 113 funds tracked by Wall St. Rank hold ATRC as of Q2 2014.

  • TFS Capital reported no remaining AtriCure position as of Q2 2014 after selling out during the quarter.
  • TFS Capital sold 57,214 AtriCure shares in Q2 2014, an estimated $1.08M.
  • TFS Capital first reported a position in AtriCure in Q2 2013 and held it in 4 quarters.
  • TFS Capital's AtriCure position peaked at $2.94M in Q4 2013.
  • 113 funds tracked by Wall St. Rank held AtriCure as of Q2 2014.

Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.